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Outbreaks of cholera in 
the time of Ebola: 
pre-emptive action 
needed
Although the pace of Ebola 
transmission has slowed in Liberia, 
Guinea, and Sierra Leone, its threat 
continues to limit the ability of 
local health-care systems to provide 
standard care, let alone respond to 
other health emergencies. These 
three Ebola-affected countries 
typically have cholera outbreaks 
every 3–5 years, with epidemics often 
spreading regionally. Cholera is now 
circulating in the region: epidemics are 
ongoing in Ghana and CÔte d’Ivoire;1,2 
the latter sharing a border with Liberia 
and Guinea. Ebola-affected countries 
might no longer be able to mobilise 
the substantial emergency staff and 
resources needed to avert deaths in 
the face of a cholera epidemic. We 
urge the public health community to 
weigh the possible consequences of 
simultaneous outbreaks of Ebola and 
cholera against the costs and feasibility 
of pre-emptive interventions.
Use of oral cholera vaccine (OCV) 
should be considered to help avert an 
additional humanitarian catastrophe 
in Ebola-affected countries. Although 
the general supply of internationally 
licensed OCV is scarce, we propose 
two strategies for the efficient 
deployment of cholera vaccine: within 
each Ebola-affected country, the 
highest cholera incidence during the 
past five years occurred in distinct areas 
(figure), which could be prioritised 
for pre-emptive vaccination; and 
in neighbouring countries, where 
cholera is circulating, delivery of OCV 
to key populations could be used to 
contain the epidemic. Restrictions 
on mass-gatherings and community 
perception of vaccination within 
Ebola-affected countries must be 
considered with any campaign design. 
We urge the Ministries of Health 
of both Ebola-affected countries 
and neighbouring cholera-affected 
countries to commence discussions 
with partners about the feasibility 
and potential effect of preventative 
OCV campaigns or the preparation for 
rapid administration of OCV, as well as 
water and sanitation inter ventions, in 
response to an outbreak.
Clinical-care providers should also 
prepare for the potential diagnostic 
and case-management challenges 
simultaneous epidemics would bring. 
Diarrhoea and vomiting, typical 
symptoms of cholera, are frequently 
present in Ebola patients, which 
could lead to challenges in triage and 
potential cross-infections within 
treatment centres. Rehydration 
therapy is key to survival from both 
diseases but must be administered so 
as to reduce risks to medical personnel 
and patients.
The true risk of cholera in the 
Ebola-affected countries is unknown, 
and some aspects of the Ebola 
response (eg, hand-washing with 
chlorine) might reduce the risk. 
However, with cholera circulating 
in the area, careful preparation 
and pre-emptive action should be 
considered to mitigate or avoid a 
potentially deadly cholera epidemic.
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Figure: 5 year incidence rates of suspected cholera in Ebola-affected countries 
Spatially smoothed estimates based on reported cases between 2009 and 2014. 
Cholera case reports are from Ministries of Health, WHO,3 and ProMED. We used 
population density estimates from WorldPop,4 and water and sanitation coverage 
data from Pullan and colleagues,5 to help distribute incidence to a finer geographic 
scale. Grey circles indicate capital cities.
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